Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Video

January 16, 2021

Alleviating Pandemic-Related Anxiety Over Returning to the Clinic for Clinical Trials

Conference|ASCO Gastrointestinal Cancers Symposium

In an interview with CURE®, expert Martha Raymond explains the importance of clinical trials during the COVID-19 pandemic and how clinicians must find a way to help ease patients anxieties as they return to the clinic.

For immunocompromised patients with cancer who may be afraid of contracting COVID-19, the pandemic has brought many things to a halt – including cancer clinical trials. That’s why Martha Raymond, the founder and CEO of The Raymond Foundation, and her colleagues set out to identify the current barriers to clinical trial participation and present their findings at this year’s ASCO Gastrointestinal Cancers Symposium.

According to Raymond, data from the National Institute of Health and the National Library of Medicine has found that 988 clinical trials were suspended from March through September, and 60% of institutions are enrolling patients into trials at a lower rate than before the pandemic. And while clinical trials offer access to the newest cancer treatments, only 2%-3% of patients enroll in a trial. Add a pandemic to the equation and clinical trial participation becomes even more difficult.

In an interview with CURE®, Raymond explained what she and her team found when they surveyed more than 500 patients about the barriers, they feel exist to clinical trial enrollment, and even in returning to the clinic for treatment during the pandemic. Their responses, Raymond explained, highlighted the need for open and honest communication between healthcare professionals and patients.

Transcription:

So, one of the big things with our patient community is that they were – and still are, to be honest with you – very frightened about what that meant, about returning to the clinic, not just for a trial if their trial had possibly resumed, but also for treatment.

And, you know, as we all know, when we're in our bubble, you try to stay as safe and secure as possible. But for cancer patients, when they're already immunocompromised, the thought of going into a hospital setting and oncology setting, it really has been very difficult for patients and, you know, totally understandable.

So, we spent a lot of time discussing this with our patients, and just going over all the layers of protection that the oncology centers are providing, and the other things that they can do on their own so that they feel more comfortable returning to the clinic.

And I think there, again, that brings the point home that it's so important, anytime in the treatment paradigm, or the trial paradigm, that that relationship with our healthcare professionals, that communication, I think now more than ever, is vitally important because patients are rightfully so very concerned. I think will be for quite some time moving forward.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with text.
Picture of Bryan Lewis
Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and aided in remission.
Related Content
Advertisement
Imfinzi plus chemo cut progression or death risk in early gastric cancer: © stock.adobe.com.
August 15th 2025

FDA Grants Priority Review to Imfinzi for Early Gastric Cancers

Spencer Feldman
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 15th 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
Image of stomach.
August 15th 2025

Imfinzi Combo Boosts Survival in Resectable Gastric and GEJ Cancer

Chris Ryan
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
August 15th 2025

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
August 15th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
Clinical trials text.
August 15th 2025

Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers

Spencer Feldman
Related Content
Advertisement
Imfinzi plus chemo cut progression or death risk in early gastric cancer: © stock.adobe.com.
August 15th 2025

FDA Grants Priority Review to Imfinzi for Early Gastric Cancers

Spencer Feldman
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 15th 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
Image of stomach.
August 15th 2025

Imfinzi Combo Boosts Survival in Resectable Gastric and GEJ Cancer

Chris Ryan
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
August 15th 2025

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
August 15th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
Clinical trials text.
August 15th 2025

Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers

Spencer Feldman
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.